Miller v. Elisea ( 2020 )


Menu:
  •                                        188
    Argued and submitted January 5, 2018, reversed and remanded
    February 12, 2020
    Sherri Kaye MILLER
    and Joshua Miller,
    Plaintiffs-Appellants,
    v.
    Cesar ELISEA,
    Defendant-Respondent,
    and
    Jane Doe ELISEA,
    Defendant.
    Multnomah County Circuit Court
    15CV29373; A164445
    459 P3d 887
    Plaintiffs appeal from a judgment dismissing their personal injury claim
    after the trial court, exercising its “gatekeeper” function to admit or exclude
    expert evidence under OEC 702, excluded the testimony of plaintiffs’ expert wit-
    nesses, who were prepared to testify that plaintiff Sherri Miller’s fibromyalgia
    was brought on by a neck injury that she sustained in a car accident caused by
    defendant. The trial court reasoned that the evidence was not scientifically valid
    because there was not consensus in the medical community that fibromyalgia
    can be brought on by physical trauma. Held: Whether there is consensus in the
    medical community concerning a theory of medical causation is relevant to the
    determination of the scientific validity of evidence, but its absence is not disqual-
    ifying. Plaintiffs’ witnesses were prepared to give testimony that was scientifi-
    cally principled and that was, therefore, scientifically valid. Defendant’s expert
    witnesses’ testimony that plaintiffs’ theory of causation did not have consensus in
    the medical community was an issue to be considered by the trier of fact but was
    not dispositive in the court’s function as a gatekeeper to admit or exclude expert
    evidence under OEC 702. The trial court erred in excluding the evidence.
    Reversed and remanded.
    Christopher J. Marshall, Judge.
    Steven P. Krafchick argued the cause and filed the briefs
    for appellants.
    Douglas F. Foley argued the cause for respondent. Also
    on the brief were Vernon Finley and Douglas Foley &
    Associates, PLLC.
    Before Armstrong, Presiding Judge, and Tookey, Judge,
    and Sercombe, Senior Judge.
    Cite as 
    302 Or App 188
     (2020)   189
    ARMSTRONG, P. J.
    Reversed and remanded.
    190                                                         Miller v. Elisea
    ARMSTRONG, P. J.
    Plaintiffs Sherri and Joshua Miller appeal from a
    judgment dismissing their personal injury claim against
    defendant after the trial court excluded the testimony of
    plaintiffs’ expert witnesses, who were prepared to testify
    that Sherri Miller’s fibromyalgia was caused by a neck
    injury that she sustained in a car accident caused by defen-
    dant. We review the trial court’s ruling excluding the evi-
    dence for legal error, Jennings v. Baxter Healtcare Corp.,
    
    331 Or 285
    , 299, 14 P3d 596 (2000), conclude that the court
    erred in excluding the evidence, and therefore reverse and
    remand.
    Several months after plaintiff Sherri Miller was
    in a minor car accident caused by defendant, she began to
    develop symptoms that were ultimately diagnosed as fibro-
    myalgia. Plaintiffs brought this personal injury action,
    seeking damages for Sherri’s injuries and for Joshua’s
    loss of consortium as a result of defendant’s negligence.
    Plaintiffs intended to call two physicians, Drs. Brown
    and Freeman, as expert witnesses who would testify that
    the physical trauma of the car accident caused Sherri’s
    fibromyalgia.
    Expert medical testimony must meet a test of “sci-
    entific validity.” Marcum v. Adventist Health System/West,
    
    345 Or 237
    , 240, 193 P3d 1 (2008). Defendant did not dispute
    the professional qualifications of Brown and Freeman or the
    diagnosis of fibromyalgia. But defendant sought to exclude
    their testimony as to causation based on the opinion of their
    own expert that there is insufficient concrete evidence of a
    causal link between physical trauma and the development
    of fibromyalgia. After a hearing under OEC 104(1),1 the trial
    court determined that plaintiffs had not met the threshold
    to establish the admissibility of the evidence as scientific
    evidence, because plaintiffs had not shown that there is a
    1
    OEC 104(1) provides:
    “Preliminary questions concerning the qualifications of a person to be a
    witness, the existence of a privilege or the admissibility of evidence shall be
    determined by the court[.]”
    Cite as 
    302 Or App 188
     (2020)                                                  191
    “consensus in the medical community” that physical trauma
    can cause fibromyalgia.2
    Plaintiffs appeal, contending that the trial court
    erred in excluding the expert testimony. Specifically, plain-
    tiffs contend that the trial court mistakenly rejected the
    evidence based on a lack of consensus in the medical com-
    munity concerning physical trauma as a potential cause of
    fibromyalgia. In response, defendant contends that there is
    no scientific support for a causal relationship between phys-
    ical trauma and fibromyalgia onset and, for that reason, the
    trial court did not err in excluding expert testimony that
    depended on a theory that Sherri’s fibromyalgia was caused
    by physical trauma.
    The Supreme Court’s most recent discussion of the
    admissibility of scientific evidence as to medical causation
    is in Marcum. There, the court considered the admissibility
    of expert testimony concerning the cause of the plaintiff’s
    vasospastic disorder. The expert, having worked through
    a differential diagnosis,3 determined that the plaintiff’s
    vasospastic disorder had been caused by an injection of
    gadolinium into the plaintiff’s hand for medical imaging,
    which had leaked from the vein into the surrounding tissue,
    causing damage. The issue in Marcum, similar to that pre-
    sented here, was the scientific validity of the expert’s theory
    of causation, in the absence of a “demonstrable mechanism
    of causation,” and for which there was not some indepen-
    dent, verifiable corroboration. 
    345 Or at 240, 249
    . The court
    described the considerations relevant to the admissibility of
    scientific evidence under OEC 401, 702, and 403, State v.
    Brown, 
    297 Or 404
    , 
    687 P2d 751
     (1984), and State v. O’Key,
    2
    The trial court explained its ruling from the bench:
    “[B]ased on all of the record that we have here and arguments of the par-
    ties, the Court’s going to find that, as its gatekeeper function on the Rule
    104 motion, that the plaintiff has not shown the required standard to show
    that consensus in the medical community, that the proffered evidence here
    about causation, meets the standard; so we would not allow the evidence of
    causation that’s been proposed here.”
    3
    “ ‘Differential diagnosis’ is an accepted technique in which ‘a doctor devel-
    ops a list of all diseases that might cause a patient’s symptoms and then, by a pro-
    cess of elimination, narrows the list’ * * * until the expert can identify the likely
    cause from among those remaining.” Marcum, 
    345 Or at
    247 (citing treatise).
    192                                                              Miller v. Elisea
    
    321 Or 285
    , 
    899 P2d 663
     (1995),4 and the court’s role as a
    “gatekeeper” in determining, based on a preponderance of
    the evidence, whether the scientific evidence is sufficiently
    valid to assist the trier of fact. Marcum, 
    345 Or at 243-45
    .
    The court noted in Marcum that the general rules for
    the admissibility of scientific evidence in Brown and O’Key,
    while helpful, provide only limited guidance on the issue of
    scientific evidence of medical causation. Marcum, 
    345 Or at 245
    . The court instead referred for guidance to Jennings,
    which had also involved a question of medical causation.
    The court in Jennings explained that the inquiry into the
    admissibility of evidence of medical causation focuses on the
    differential diagnosis and whether the particular use of the
    differential diagnosis to determine causation has met the
    general test of scientific validity. 
    331 Or at 307
    . There the
    court had also concluded that OEC 702 does not preclude the
    admission of “novel” theories of causation that are scientifi-
    cally valid. 
    Id.
    In Marcum, the court explained that the consider-
    ations that bear on the scientific validity of a differential
    diagnosis will vary depending on the type of injury. 
    345 Or at 248
    . For example, the court explained, in a case involv-
    ing a toxic exposure, reliable testimony of causation might
    require extremely accurate data and methods, peer-reviewed
    studies, and small and controlled error rates, to “rule in”
    a possible cause. 
    Id.
     In a case such as Marcum, involving
    a single event, where the injury was immediate and local-
    ized, it may be possible to rule in the exposure when there
    are few obvious alternative causes. 
    Id. at 249
    . The court
    explained that, when “ruling in” a potential cause, “a trial
    court should insist that the causation theory be biologically
    plausible, that is, that the exposure could have caused the
    4
    The primary source of a trial court’s gatekeeping function with respect to
    expert testimony is OEC 702, which provides:
    “If scientific, technical or other specialized knowledge will assist the trier
    of fact to understand the evidence or to determine a fact in issue, a witness
    qualified as an expert by knowledge, skill, experience, training or education
    may testify thereto in the form of an opinion or otherwise.”
    Scientific knowledge does not assist the trier of fact if it is not sufficiently valid or
    reliable to warrant the unusually high degree of persuasive power that it is likely
    to have. O’Key, 
    321 Or at 291
    .
    Cite as 
    302 Or App 188
     (2020)                              193
    injury.” 
    Id.
     A particular possible cause should not neces-
    sarily be excluded “on the ground that the expert cannot
    describe the precise mechanism of causation or point to sta-
    tistical studies of cause and effect.” 
    Id.
    The court in Marcum described the factors relied on
    by the plaintiff’s expert, including his own clinical experi-
    ences and observations, a review of medical literature, the
    suddenness of the onset of the plaintiff’s symptoms after
    the injection, and the elimination of other potential causes.
    
    Id.
     The court explicitly rejected the defendant’s view that
    the expert’s testimony must be excluded in the absence of
    a well-understood mechanism of cause or published studies
    and acceptance of the particular theory of causation by the
    medical community. 
    Id. at 250-51
    . The court concluded that
    the plaintiff had made an adequate showing of a scientifi-
    cally valid reason for “ruling in” gadolinium extravasation
    as a potential cause of her vasospastic disorder. 
    Id.
    As in Marcum, the focus of this appeal is on the
    narrow question of the admissibility of scientific evidence of
    medical causation—specifically on whether the trial court
    erred in concluding that the opinions of plaintiffs’ experts,
    who believed that physical trauma should be included among
    potential causes in a differential diagnosis of fibromyalgia,
    were scientifically valid in the absence of consensus in the
    medical community that physical trauma can cause fibro-
    myalgia. The trial court’s rationale here for excluding the
    disputed evidence was that, in the absence of concurrence
    in the medical community as to a theory of causation, the
    theory is not scientifically valid.
    We disagree with the trial court. As the court said
    in Marcum, the general acceptance of a theory of causation
    in the medical community is certainly relevant to the deter-
    mination of the scientific validity of a theory, but its absence
    is not disqualifying. 
    Id. at 250-53
     (absence of corroboration
    of the theory of medical causation through studies and com-
    parisons is not a basis for exclusion of a theory of causation
    that is biologically plausible); see Jennings, 
    331 Or at 308-09
    (although the degree of acceptance in the relevant commu-
    nity is a factor under O’Key, the admissibility of scientific
    evidence does not depend on peer acceptance or publication);
    194                                           Miller v. Elisea
    Kennedy v. Eden Advanced Pest Technologies, 
    222 Or App 431
    , 446, 193 P3d 1030 (2008) (a difference of opinion in the
    scientific community alone is not a basis to exclude scientific
    evidence).
    Here, plaintiffs’ experts supported their theory that
    physical trauma can cause fibromyalgia with evidence from
    their own clinical experience that there is a high correlation
    between physical trauma and fibromyalgia, peer-reviewed
    medical literature, and studies describing a possible neuro-
    logical mechanism of causation. Freeman, an epidemiologist,
    described the process by which he determines whether a fac-
    tor belongs in the causal framework, including an analysis
    of “plausibility,” temporal relationship, and alternative
    explanations. In addressing plausibility, Freeman described
    a condition known as central sensitization, thought to be
    a mechanism of fibromyalgia. The condition, recognized
    in the medical literature and thought to be brought on by
    trauma, exists when the brain and spinal cord interpret
    a normally nonpainful stimulus as painful. Freeman also
    addressed the temporal relationship of Sherri’s fibromyalgia
    to the car accident, and explained that Sherri’s development
    of the condition was well within the typical time frame for
    the development of fibromyalgia after a traumatic event.
    Freeman also explained that, although Sherri’s medical his-
    tory showed that she had several preexisting conditions that
    were potentially related to central sensitization and “was
    somewhat fragile,” until the accident, there was no record of
    escalating and increasingly frequent complaints of spread-
    ing pain, as characteristic of fibromyalgia.
    Plaintiffs’ evidence is of the type that the court in
    Jennings and Marcum said is scientifically valid under the
    Brown/O’Key factors. It is true that defendant’s witness,
    Dr. Wolfe, contradicted Freeman, based on his own conclu-
    sion that there is no consensus in the medical community
    as to a connection between physical trauma and fibromyal-
    gia, and his own conclusion that evidence to date showing
    a relationship between the two is unreliable because it has
    depended on patient self-reporting. Those issues are rele-
    vant but are for the trier of fact to consider in weighing the
    evidence; they are not dispositive in the court’s function as
    Cite as 
    302 Or App 188
     (2020)                             195
    a gatekeeper to admit or exclude expert evidence. O’Key,
    
    321 Or at
    301 n 18 (“A trial court, acting as a gatekeeper,
    does not sit as a trier of fact to determine which side has
    presented the more credible (or more persuasive) expert or
    scientific evidence.”). Rather, the trial court’s function was
    to determine whether the offered evidence was based on sci-
    entifically valid principles. 
    Id. at 303
    . We conclude here that
    it was. The trial court therefore erred in excluding the testi-
    mony of Brown and Freeman, and we reverse the judgment.
    Reversed and remanded.
    

Document Info

Docket Number: A164445

Judges: Armstrong

Filed Date: 2/12/2020

Precedential Status: Precedential

Modified Date: 10/10/2024